Crystal structures of the pro-inflammatory cytokine interleukin-23 and its complex with a high-affinity neutralizing antibody

被引:50
作者
Beyer, Brian M. [1 ]
Ingram, Richard [1 ]
Ramanathan, Lata [1 ]
Reichert, Paul [1 ]
Le, Hung V. [1 ]
Madison, Vincent [1 ]
Orth, Peter [1 ]
机构
[1] Schering Plough Res Inst, Kenilworth, NJ 07033 USA
关键词
IL-23; cytokine; Fab; receptor; crystal structure;
D O I
10.1016/j.jmb.2008.08.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interleukin (IL)-23 is a pro-inflammatory cytokine playing a key role in the pathogenesis of several autoimmune and inflammatory diseases. We have determined the crystal structures of the heterodimeric p19-p40 IL-23 and its complex with the Fab (antigen-binding fragment) of a neutralizing antibody at 2.9 and 1.9 angstrom, respectively. The IL-23 structure closely resembles that of IL-12. They share the common p40 subunit, and IL-23 p19 overlaps well with IL-12 p35. Along the hydrophilic heterodimeric interface, fewer charged residues are involved for IL-23 compared with IL-12. The binding site of the Fab is located exclusively on the p19 subunit, and comparison with published cytokine-receptor structures suggests that it overlaps with the IL-23 receptor binding site. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:942 / 955
页数:14
相关论文
共 34 条
[1]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[2]  
BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582
[3]   Hexameric structure and assembly of the interleukin-6/IL-6 α-receptor/gp130 complex [J].
Boulanger, MJ ;
Chow, DC ;
Brevnova, EE ;
Garcia, KC .
SCIENCE, 2003, 300 (5628) :2101-2104
[4]   Crystal structure of a cytokine-binding region of gp130 [J].
Bravo, J ;
Staunton, D ;
Heath, JK ;
Jones, EY .
EMBO JOURNAL, 1998, 17 (06) :1665-1674
[5]   Bayesian statistical viewpoint on structure determination: Basic concepts and examples [J].
Bricogne, G .
MACROMOLECULAR CRYSTALLOGRAPHY, PT A, 1997, 276 :361-423
[6]   Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis [J].
Chen, Y ;
Langrish, CL ;
Mckenzie, B ;
Joyce-Shaikh, B ;
Stumhofer, JS ;
McClanahan, T ;
Blumenschein, W ;
Churakovsa, T ;
Low, J ;
Presta, L ;
Hunter, CA ;
Kastelein, RA ;
Cua, DJ .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (05) :1317-1326
[7]   Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain [J].
Cua, DJ ;
Sherlock, J ;
Chen, Y ;
Murphy, CA ;
Joyce, B ;
Seymour, B ;
Lucian, L ;
To, W ;
Kwan, S ;
Churakova, T ;
Zurawski, S ;
Wiekowski, M ;
Lira, SA ;
Gorman, D ;
Kastelein, RA ;
Sedgwick, JD .
NATURE, 2003, 421 (6924) :744-748
[8]  
DeLano W. L., 2002, PYMOL
[9]   A genome-wide association study identifies IL23R as an inflammatory bowel disease gene [J].
Duerr, Richard H. ;
Taylor, Kent D. ;
Brant, Steven R. ;
Rioux, John D. ;
Silverberg, Mark S. ;
Daly, Mark J. ;
Steinhart, A. Hillary ;
Abraham, Clara ;
Regueiro, Miguel ;
Griffiths, Anne ;
Dassopoulos, Themistocles ;
Bitton, Alain ;
Yang, Huiying ;
Targan, Stephan ;
Datta, Lisa Wu ;
Kistner, Emily O. ;
Schumm, L. Philip ;
Lee, Annette T. ;
Gregersen, Peter K. ;
Barmada, M. Michael ;
Rotter, Jerome I. ;
Nicolae, Dan L. ;
Cho, Judy H. .
SCIENCE, 2006, 314 (5804) :1461-1463
[10]   Parameter optimized surfaces (POPS): analysis of key interactions and conformational changes in the ribosome [J].
Fraternali, F ;
Cavallo, L .
NUCLEIC ACIDS RESEARCH, 2002, 30 (13) :2950-2960